- Home
- EQH vs SLRX Comparison
EQH vs SLRX Comparison
Compare EQH & SLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EQH
- SLRX
- Stock Information
- Founded
- EQH 1859
- SLRX N/A
- Country
- EQH United States
- SLRX United States
- Employees
- EQH N/A
- SLRX N/A
- Industry
- EQH Specialty Insurers
- SLRX Biotechnology: Pharmaceutical Preparations
- Sector
- EQH Finance
- SLRX Health Care
- Exchange
- EQH Nasdaq
- SLRX Nasdaq
- Market Cap
- EQH 16.2B
- SLRX 2.9M
- IPO Year
- EQH N/A
- SLRX N/A
- Fundamental
- Price
- EQH $52.80
- SLRX $5.69
- Analyst Decision
- EQH Buy
- SLRX
- Analyst Count
- EQH 11
- SLRX 0
- Target Price
- EQH $64.55
- SLRX N/A
- AVG Volume (30 Days)
- EQH 2.7M
- SLRX 285.6K
- Earning Date
- EQH 11-03-2025
- SLRX 11-13-2025
- Dividend Yield
- EQH 2.05%
- SLRX N/A
- EPS Growth
- EQH N/A
- SLRX N/A
- EPS
- EQH 1.38
- SLRX N/A
- Revenue
- EQH $13,960,000,000.00
- SLRX N/A
- Revenue This Year
- EQH $17.36
- SLRX N/A
- Revenue Next Year
- EQH $1.25
- SLRX N/A
- P/E Ratio
- EQH $38.17
- SLRX N/A
- Revenue Growth
- EQH 21.29
- SLRX N/A
- 52 Week Low
- EQH $40.38
- SLRX $4.50
- 52 Week High
- EQH $56.61
- SLRX $108.00
- Technical
- Relative Strength Index (RSI)
- EQH 47.94
- SLRX 44.79
- Support Level
- EQH $52.40
- SLRX $4.79
- Resistance Level
- EQH $54.43
- SLRX $5.65
- Average True Range (ATR)
- EQH 1.12
- SLRX 0.45
- MACD
- EQH -0.03
- SLRX 0.25
- Stochastic Oscillator
- EQH 43.56
- SLRX 66.85
About EQH Equitable Holdings Inc.
Equitable Holdings Inc is a financial services company in the U.S. The company provides variable annuities, tax-deferred investment and retirement plans, employee benefits, and protection solutions for individuals, families, and small businesses. Its business segments include Individual Retirement, Group Retirement, Asset Management, Protection Solutions, Wealth Management, and Legacy. It generates the majority of its revenue from the Asset Management segment which provides diversified investment management and related solutions globally to a broad range of clients through three main client channels - Institutional, Retail, and Private Wealth.
About SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.